NCT04932395

Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis

An Adaptive Enrichment Designed, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of Anshen Buxin Liuwei Pills in the Treatment of Cardiac Neurosis

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study aims to assess the effect and safety of the traditional Mongolian medicine Anshen Buxin Liuwei Pill for the treatment of cardiac neurosis.

Detailed description

Cardiac neurosis is a group of symptoms characterized by the coexistence of cardiovascular disease related symptoms and nervous system disorders. Anshen Buxin Liuwei Pill is a kind of traditional Mongolian medicine for the treatment of cardiac neurosis. This study aims to evaluate the effect and safety of Anshen Buxin Liuwei Pill for cardiac neurosis in a prospective, randomized, double-blind, placebo-controlled clinical trial.

Conditions

• Cardiac Neurosis

Interventions

Type	Name	Description
DRUG	Anshen Buxin Liuwei Pill	15 capsules/time, 2 times/day, orally.
DRUG	Placebo	Placebo simulated as the Anshen Buxin Liuwei Pills with same appearance，smell and taste,15 capsules/time, 2 times/day, orally.

Timeline

• Start date: 2021-06-22
• Primary completion: 2023-12-01
• Completion: 2024-06-01
• First posted: 2021-06-21
• Last updated: 2022-11-15

Locations

7 sites across 1 country: China